ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 83 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $293,000 | +29.6% | 281,983 | -7.0% | 0.01% | +10.0% |
| Q4 2018 | $226,000 | -64.9% | 303,071 | 0.0% | 0.01% | -56.5% |
| Q3 2018 | $643,000 | -8.1% | 303,071 | 0.0% | 0.02% | -11.5% |
| Q2 2018 | $700,000 | -27.6% | 303,071 | -0.3% | 0.03% | -27.8% |
| Q1 2018 | $967,000 | -22.4% | 303,971 | 0.0% | 0.04% | -16.3% |
| Q4 2017 | $1,246,000 | -9.3% | 303,971 | 0.0% | 0.04% | -10.4% |
| Q3 2017 | $1,374,000 | +1.2% | 303,971 | -25.4% | 0.05% | +2.1% |
| Q2 2017 | $1,358,000 | -55.5% | 407,741 | +23.1% | 0.05% | -56.5% |
| Q1 2017 | $3,051,000 | +56.9% | 331,296 | +31.3% | 0.11% | +54.3% |
| Q4 2016 | $1,945,000 | -41.2% | 252,228 | -12.9% | 0.07% | -41.7% |
| Q3 2016 | $3,309,000 | -7.2% | 289,528 | 0.0% | 0.12% | -7.7% |
| Q2 2016 | $3,564,000 | +67.6% | 289,528 | +37.6% | 0.13% | +71.1% |
| Q1 2016 | $2,127,000 | -55.1% | 210,403 | 0.0% | 0.08% | -50.6% |
| Q4 2015 | $4,742,000 | +35.8% | 210,403 | 0.0% | 0.15% | +36.3% |
| Q3 2015 | $3,491,000 | -15.2% | 210,403 | +15.0% | 0.11% | -3.4% |
| Q2 2015 | $4,118,000 | +242.3% | 183,003 | +292.3% | 0.12% | +234.3% |
| Q1 2015 | $1,203,000 | – | 46,654 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|